CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...

A Senate panel has advanced three sets of bipartisan bills purportedly aimed at reforming the intellectual property (IP) ...

Sonia T. Oskouei, PharmD, emphasized strategies to streamline regulations and evolve to overcome barriers and expand the ...

Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to ...